http://www.hammerstockblog.com/micromet-continues-to-over-deliver/ Biotech stock reviews Sat, 13 Mar 2010 17:54:45 +0000 http://wordpress.org/?v=2.3.1 http://www.hammerstockblog.com/micromet-continues-to-over-deliver/#comment-653 TheTradingReport » Blog Archive » Bright Prospects for Micromet (Part 1) Fri, 24 Apr 2009 16:35:43 +0000 http://www.hammerstockblog.com/micromet-continues-to-over-deliver/#comment-653 [...] Last summer, Micromet’s stock climbed to $7 following excellent clinical data (discussed here) and a landmark publication in Science Magazine (discussed here), but since then the company has [...] […] Last summer, Micromet’s stock climbed to $7 following excellent clinical data (discussed here) and a landmark publication in Science Magazine (discussed here), but since then the company has […]

]]> http://www.hammerstockblog.com/micromet-continues-to-over-deliver/#comment-652 TheTradingReport » Blog Archive » Bright Prospects for Micromet and Medimmune (Part 1) Fri, 24 Apr 2009 15:58:28 +0000 http://www.hammerstockblog.com/micromet-continues-to-over-deliver/#comment-652 [...] Last summer, Micromet’s stock climbed to $7 following excellent clinical data (discussed here) and a landmark publication in Science Magazine (discussed here), but since then the company has [...] […] Last summer, Micromet’s stock climbed to $7 following excellent clinical data (discussed here) and a landmark publication in Science Magazine (discussed here), but since then the company has […]

]]>